Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase.
Age: 18 years - 66+
Gender: All
We've found 1 total result for "KennyCaffey syndrome Type 1".
We've found 1 total result for "KennyCaffey syndrome Type 1".
Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase.
Age: 18 years - 66+
Gender: All